The present findings highlight the pivotal role of ubiquitin dysregulation in the early stages of airway fibrosis and provide a molecular foundation for exploring UbC-targeted interventions in the prevention and treatment of bronchiolitis obliterans. This evidence concerns the gene UBA52 and fibrosis.